TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Emerging Infectious Diseases
Researchers at Seoul National University target emerging infectious diseases
March 25th, 2008
"Despite the concern of replacement disease, notably by serotype 19A after 7-valent conjugate vaccine (PCV7) use, serotype 19A was increasingly recognized in Korean children before the introduction of PCV7. To understand the dynamics of serogroup 19 prevalence from 1991-2006, we serotyped 538 pediatric pneumococcal isolates," investigators in Seoul, South Korea report. "Serogroup 19 isolates (n = 126) were characterized by antimicrobial drug susceptibility, presence of mefAlermB, and multilocus sequence typing. Overall, the proportion of serotype 19A isolates increased but serotype 19F decreased. Among children <5 years of age, the proportion of serotype 19A isolates...
Source: TB & Outbreaks Week (2008-03-25)
|
